✦ LIBER ✦

The Residual Risk Reduction Initiative: A Call to Action to Reduce Residual Vascular Risk in Patients with Dyslipidemia

✍ Scribed by Jean-Charles Fruchart; Frank Sacks; Michel P. Hermans; Gerd Assmann; W. Virgil Brown; Richard Ceska; M. John Chapman; Paul M. Dodson; Paola Fioretto; Henry N. Ginsberg; Takashi Kadowaki; Jean-Marc Lablanche; Nikolaus Marx; Jorge Plutzky; Željko Reiner; Robert S. Rosenson; Bart Staels; Jane K. Stock; Rody Sy; Christoph Wanner; Alberto Zambon; Paul Zimmet

Book ID: 113445311
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 826 KB
Volume: 102
Category: Article
ISSN: 0002-9149
DOI: 10.1016/j.amjcard.2008.10.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Usefulness of Statin–Ezetimibe Combinati

Usefulness of Statin–Ezetimibe Combination to Reduce the Care Gap in Dyslipidemia Management in Patients With a High Risk of Atherosclerotic Disease

✍ Hwee Teoh; Aurora A. Mendelsohn; Shaun G. Goodman; Shahin Jaffer; Richard Y.Y. C 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 529 KB

The atherogenic dyslipidemia ratio [log(

The atherogenic dyslipidemia ratio [log(TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes females

✍ Michel P Hermans, Sylvie A Ahn, Michel F Rousseau 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 213 KB

RESULTS FROM THE FENOFIBRIC ACID ON CARO

RESULTS FROM THE FENOFIBRIC ACID ON CAROTID INTIMA-MEDIA THICKNESS IN SUBJECTS WITH TYPE IIB DYSLIPIDEMIA WITH RESIDUAL RISK IN ADDITION TO ATORVASTATIN THERAPY (FIRST) TRIAL

✍ Davidson, Michael H.; Rosenson, Robert; Maki, Kevin; Nicholls, Stephen; Ballanty 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Residual Tumor Size and IGCCCG Risk Clas

Residual Tumor Size and IGCCCG Risk Classification Predict Additional Vascular Procedures in Patients with Germ Cell Tumors and Residual Tumor Resection: A Multicenter Analysis of the German Testicular Cancer Study Group

✍ Christian Winter; David Pfister; Jonas Busch; Cigdem Bingöl; Ulrich Ranft; Mark 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 452 KB

Study Design, Rationale, and Baseline Ch

Study Design, Rationale, and Baseline Characteristics: Evaluation of Fenofibric Acid on Carotid Intima-Media Thickness in Patients with Type IIb Dyslipidemia with Residual Risk in Addition to Atorvastatin Therapy (FIRST) Trial

✍ Michael Davidson, Robert S. Rosenson, Kevin C. Maki, Stephen J. Nicholls, Christ 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 300 KB

Re: Residual Tumor Size and IGCCCG Risk

Re: Residual Tumor Size and IGCCCG Risk Classification Predict Additional Vascular Procedures in Patients with Germ Cell Tumors and Residual Tumor Resection: A Multicenter Analysis of the German Testicular Cancer Study Group

✍ Richie, Jerome P. 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 105 KB